pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

6,271 catalysts · 6,271 phase readout · 2,302 8k filing · 390 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 31 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: grant×type: filing×clear all
type
  • phase readout6,271
  • 8k filing2,302
  • earnings390
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07012382: Single Gene Polymorphism and the Success Rate of Inferior Alveolar Nerve Block

Sponsor: Jamia Millia Islamia. Phase: NA. Conditions: Pulpitis - Irreversible

full page →ctgov ↗
›RECRUITINGphase readoutNCT07454824: e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most

Sponsor: Johns Hopkins University. Phase: NA. Conditions: Dementia, Potentially Inappropriate Medication Use, Mild Cognitive Impairment (MCI)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07556523: Patient Quality of Recovery After TAVR With Different Sedation Regimens

Sponsor: David Lyubashevsky. Phase: PHASE4. Conditions: Transcatheter Aortic Valve Replacement (TAVR), Aortic Valve Stenosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06729996: Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis/Acute Pancreatitis Associated Diabetes Mellitus

Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Pancreatitis, Chronic, Pancreatitis, Acute, Diabetes Mellitus

full page →ctgov ↗
›RECRUITINGphase readoutNCT03786796: Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: PHASE2. Conditions: Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer, Renal Carcinoma, Kidney Cancer Metastatic

full page →ctgov ↗
›RECRUITINGphase readoutNCT07456696: An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)

Sponsor: Transcend Therapeutics. Phase: PHASE3. Conditions: Post Traumatic Stress Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07153796: A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: B-cell Acute Lymphoblastic Leukemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07712796: Empowerment Self Defense Program for Adult Native Women Survivors of Sexual Violence

Sponsor: University of Michigan. Phase: NA. Conditions: Depression and Quality of Life, Sexual Violence, PTSD, Suicidal Ideation, Problem Drinking

full page →ctgov ↗
›RECRUITINGphase readoutNCT06722846: Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Randomized Case Vignette Study.

Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Health Options, Strategic Care Planning

full page →ctgov ↗
›COMPLETEDphase readoutNCT03329196: Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan

Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Anemia; Non-dialysis Dependent Chronic Kidney Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07595562: Acceptability of Soy Milk as a Calcium-Rich Beverage in School Children in New York City Public Schools

Sponsor: Physicians Committee for Responsible Medicine. Phase: . Conditions: Food Acceptance, Soy Milk, Schools, New York, Acceptance, Choice, Beverage, Food Waste, Food Tasting

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07223762: Hyperangulated Versus Standard Geometry Laryngoscope Blade Trial

Sponsor: Vanderbilt University Medical Center. Phase: NA. Conditions: Acute Respiratory Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT05977803: Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary Origin

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Brain Metastases, Radionecrosis, Pulmonary Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03700203: Cardiac Arrest Pursuit Trial With Unique Registration and Epidemiologic Surveillance

Sponsor: Seoul National University Hospital. Phase: . Conditions: Cardiac Arrest, Out-Of-Hospital

full page →ctgov ↗
›WITHDRAWNphase readoutNCT02943642: Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides

Sponsor: Virogen Biotechnology Inc.. Phase: PHASE2. Conditions: Mycosis Fungoides

full page →ctgov ↗
›COMPLETEDphase readoutNCT02661542: Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas

Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc.. Phase: PHASE1. Conditions: Solid Tumors, Lymphomas

full page →ctgov ↗
›RECRUITINGphase readoutNCT07307170: The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster

Sponsor: Beijing Tiantan Hospital. Phase: NA. Conditions: Herpes Zoster, Mirogabalin, Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT05962970: Continuous Adductor Canal Block in Fast Track Total Knee Arthroplasty

Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital. Phase: NA. Conditions: Total Knee Arthroplasty

full page →ctgov ↗
›RECRUITINGphase readoutNCT07380269: Cochlear Implant Recipients: Comprehensive Longitudinal Evaluation

Sponsor: Eye & ENT Hospital of Fudan University. Phase: . Conditions: Hearing Loss, Hearing Loss, Sensorineural, Deafness, Cochlear Implantation, Speech Perception

full page →ctgov ↗
›RECRUITINGphase readoutNCT06474273: TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients

Sponsor: University of Sydney. Phase: PHASE3. Conditions: Rejection; Transplant, Kidney, Rejection; Transplant, Pancreas

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04234373: Effect of a Low-carb Dietary Intervention in Obese Patients: a Pilot Trial

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Glucose Intolerance, Obesity

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07362173: Actualities in Procedural Sedation: Remimazolam

Sponsor: Iuliu Hatieganu University of Medicine and Pharmacy. Phase: PHASE4. Conditions: ASA Class III/IV Patients, COPD III/IV, Age 65 and Older, Multiple Organ Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT07548073: Effect of Scene-Based Training on Cognitive Function in Patients With Alzheimer's Disease

Sponsor: Zhejiang Provincial Tongde Hospital. Phase: NA. Conditions: Alzheimer Disease, Cognitive Dysfunction, Mild Cognitive Impairment

full page →ctgov ↗
›COMPLETEDphase readoutNCT01892189: Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults

Sponsor: Takeda. Phase: PHASE1. Conditions: Ketamine-Induced Brain Activity Changes, Psychotic-like Symptoms

full page →ctgov ↗
›RECRUITINGphase readoutNCT06696768: Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Metastatic Colorectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Unresectable Colorectal Adenocarcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT03053791: Deep Brain Stimulation in Patients With Incomplete Spinal Cord Injury for Improvement of Gait

Sponsor: University of Zurich. Phase: NA. Conditions: Spinal Cord Injury

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07475091: Standardizing Swallow Pressure Measurements

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Dysphagia

full page →ctgov ↗
›COMPLETEDphase readoutNCT04932291: Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population

Sponsor: Oryzon Genomics S.A.. Phase: PHASE2. Conditions: Borderline Personality Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06334991: Study for Participants With Relapsed/Refractory Non-Hodgkin Lymphoma

Sponsor: ImmunityBio, Inc.. Phase: PHASE1. Conditions: Non-Hodgkin Lymphoma Refractory/ Relapsed

full page →ctgov ↗
›RECRUITINGphase readoutNCT06175091: Impact of an Alarm Management Protocol on Noise Pollution and Patient Safety in Intensive Care Units

Sponsor: Centre Hospitalier Universitaire de Saint Etienne. Phase: NA. Conditions: Intensive Care Unit

full page →ctgov ↗
›COMPLETEDphase readoutNCT01563874: Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Lymphoma, Lymphoid Hyperplasia

full page →ctgov ↗
›RECRUITINGphase readoutNCT05500807: Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois. Phase: PHASE1. Conditions: Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06434207: Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis

Sponsor: Boston Children's Hospital. Phase: . Conditions: Congenital Heart Disease, Single-ventricle, Thrombosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07522892: Physiological Safety and Behavioral Comfort of Swaddle Bathing in Preterm Infants

Sponsor: Chang Gung University of Science and Technology. Phase: NA. Conditions: Preterm Infants

full page →ctgov ↗
›COMPLETEDphase readoutNCT06222892: A Study of Camlipixant in Male and Female Healthy Participants and Participants With Hepatic Impairment Aged 18-75 Years of Age

Sponsor: Bellus Health Inc. - a GSK company. Phase: PHASE1. Conditions: Cough

full page →ctgov ↗
›COMPLETEDphase readoutNCT07617207: Impact of the Training to Aid Patients With Stroke Program on Caregiver Knowledge, Burden, and Quality of Life

Sponsor: University of the Philippines Manila - Philippine General Hospital. Phase: NA. Conditions: Stroke, Stroke Rehabilitation, Stroke Rehabilitation and Caregivers, Quality of Life

full page →ctgov ↗
›COMPLETEDphase readoutNCT03023007: Study Evaluating the Efficacy of Loco-regional Anaesthesia PECS on Chronic Pain of a Mastectomy

Sponsor: Centre Oscar Lambret. Phase: NA. Conditions: Breastcancer, Mastectomy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07379307: EFFECT OF DİFFERENT POSİTİONS ON PAİN AND COMFORT DURİNG FETAL MONİTORİNG İN OBESE PREGNANT WOMEN

Sponsor: Tokat Gaziosmanpasa University. Phase: NA. Conditions: Obesity in Pregnancy, Maternal Comfort During Fetal Monitoring

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03842592: Ventricular Arrhythmia After Myocarditis in Sportsman

Sponsor: University Hospital, Angers. Phase: NA. Conditions: Myocarditis Acute, Ventricular Arrythmia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07642492: REcovery After Cancer Application

Sponsor: Karolinska Institutet. Phase: NA. Conditions: Oesophageal Cancer, Gastric Cancer (Diagnosis)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05373836: Relationship of PNI and Clinical Outcome in Patients Undergoing Brain Tumor Surgery

Sponsor: Seoul National University Hospital. Phase: . Conditions: Clinical Outcome

full page →ctgov ↗
›RECRUITINGphase readoutNCT06494111: Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Lymphedema, Fibrosis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07747207: PULSTA TPV Observational Study

Sponsor: Taewoong Medical Co., Ltd.. Phase: . Conditions: Heart Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT03887936: Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism

Sponsor: VA Office of Research and Development. Phase: PHASE4. Conditions: Type 2 Diabetes Mellitus, Hypogonadism

full page →ctgov ↗
›COMPLETEDphase readoutNCT07322536: The Impact of Interactive Virtual Reality Training Using Haptic Gloves on Intensive Care Nurses' Aspiration Skills and Care Behaviors

Sponsor: Ela YILMAZ COŞKUN. Phase: NA. Conditions: Nursing Caries, Intensive Care Nursing, Aspiration, Virtual Reality

full page →ctgov ↗
›COMPLETEDphase readoutNCT07409636: A Study to Assess the Real-World Effectiveness of Inclisiran and PCSK9 mAbs in Chinese Hypercholesterolemia Adult Patients

Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Hypercholesterolemia, Mixed Dyslipidemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07501611: Acute Cardiovascular Effects of Transcutaneous Auricular Vagus Nerve Stimulation

Sponsor: Northumbria University. Phase: NA. Conditions: Vagus Nerve Stimulations

full page →ctgov ↗
›RECRUITINGphase readoutNCT07352592: Process-Based Approach Case Series For Anxiety Problems

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Anxiety

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05729711: TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)

Sponsor: AstraZeneca. Phase: . Conditions: Bronchial Asthma (Only the Patients With Severe or Intractable Bronchial Asthma Which Could Not be Controlled With the Existing Therapy)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07346092: Studying the Health Perceptions and Social Behaviors of Graduate Students at the Ohio State University for the Development of Effective Oral Nicotine Pouch Addictive Risk Communication

Sponsor: Ohio State University Comprehensive Cancer Center. Phase: NA. Conditions: Tobacco-Related Carcinoma

full page →ctgov ↗
← prev
page 124 of 126
next →